✦ LIBER ✦

Colchicine induced remission in amyloid nephrotic syndrome

✍ Scribed by R. Oren; G. Pizov; Y. Naparstek; A. Rubinow

Book ID: 105504785
Publisher: Springer
Year: 1993
Tongue: English
Weight: 378 KB
Volume: 12
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02231786

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longterm complete remission of AL-amyloi

Longterm complete remission of AL-amyloid-related nephrotic syndrome

✍ Yoshihide Fujigaki; Satoru Takahashi; Katsuhiko Yonemura; Hiroyuki Suzuki; Akash 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 497 KB

Cyclosporine A induced remission of rela

Cyclosporine A induced remission of relapsing nephrotic syndrome in children

✍ Tejani, Amir; Butt, Khalid; Trachtman, Howard; Suthanthiran, Manikkam; Rosenthal 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 539 KB

Hyperlipidemic profiles during remission

Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome

✍ A. Mérouani; E. Lévy; J.-G. Mongeau; P. Robitaille; M. Lambert; E.E. Delvin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Vitamin D insufficiency in steroid-sensi

Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission

✍ Francis L. Weng; Justine Shults; Rita M. Herskovitz; Babette S. Zemel; Mary B. L 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 232 KB

Remission of myasthenia gravis caused by

Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome

✍ Malaz Almsaddi; Tulio E. Bertorini; William Bastnagel 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylc

Mycophenolate mofetil versus cyclosporin

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

✍ Eiske M. Dorresteijn; Joana E. Kist-van Holthe; Elena N. Levtchenko; Jeroen Naut 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 194 KB

We performed a multi-centre randomized controlled trial to compare the efficacy of mycophenolate mofetil (MMF) to that of cyclosporine A (CsA) in treating children with frequently relapsing nephrotic syndrome and biopsy-proven minimal change disease. Of the 31 randomized initially selected patients,